HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jinjin Yu Selected Research

tectoridin

10/2022Tectoridin alleviates lipopolysaccharide-induced inflammation via inhibiting TLR4-NF-κB/NLRP3 signaling in vivo and in vitro.
8/2022Tectoridin ameliorates proliferation and inflammation in TNF-α-induced HFLS-RA cells via suppressing the TLR4/NLRP3/NF-κB signaling pathway.
1/2022Tectoridin exhibits anti-rheumatoid arthritis activity through the inhibition of the inflammatory response and the MAPK pathway in vivo and in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jinjin Yu Research Topics

Disease

14Neoplasms (Cancer)
05/2022 - 04/2012
10Inflammation (Inflammations)
10/2022 - 01/2019
8Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2019 - 04/2012
6Atherosclerosis
09/2021 - 10/2019
6Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 05/2015
3Neoplasm Metastasis (Metastasis)
05/2022 - 05/2015
2Rheumatoid Arthritis
08/2022 - 01/2022
2Cardiovascular Diseases (Cardiovascular Disease)
07/2021 - 11/2017
2Ovarian Epithelial Carcinoma
08/2020 - 01/2018
2Endometrial Neoplasms (Endometrial Cancer)
03/2014 - 03/2014
1Shock
10/2022
1Carcinogenesis
05/2022
1Hepatocellular Carcinoma (Hepatoma)
05/2022
1Keratoconus
05/2022
1Arthritis (Polyarthritis)
01/2022
1Wounds and Injuries (Trauma)
01/2022
1Acute Lung Injury
01/2022
1Hyperlipidemias (Hyperlipidemia)
09/2021
1Arteriosclerosis
04/2021
1Uveitis
02/2021
1Diverticulum
01/2021
1Cicatrix (Scar)
01/2021
1Melanoma (Melanoma, Malignant)
11/2020
1Aphakia
07/2020
1Lens Subluxation
07/2020
1Cataract (Cataracts)
07/2020
1Myopia
01/2020
1Macular Edema
01/2020
1Reperfusion Injury
01/2020
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2020
1Adenocarcinoma of Lung
10/2019
1Vascular Diseases (Vascular Disease)
10/2019
1Starvation
08/2018
1Infections
06/2018
1Lymphatic Metastasis
01/2018
1Breast Diseases (Breast Disease)
01/2018

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
05/2022 - 11/2017
5Long Noncoding RNAIBA
10/2019 - 11/2015
4Biological ProductsIBA
08/2022 - 05/2015
4Biomarkers (Surrogate Marker)IBA
08/2020 - 01/2018
3tectoridinIBA
10/2022 - 01/2022
3Cyclin D1IBA
01/2019 - 03/2014
2LipopolysaccharidesIBA
10/2022 - 01/2022
2Messenger RNA (mRNA)IBA
05/2022 - 03/2014
2Apolipoproteins E (ApoE)IBA
09/2021 - 04/2021
2oxidized low density lipoproteinIBA
09/2021 - 03/2020
2epicatechin gallateIBA
09/2021 - 01/2021
2Polysaccharides (Glycans)IBA
04/2021 - 03/2020
2HydrogelsIBA
02/2021 - 11/2020
2BuforminIBA
10/2018 - 01/2018
2CateninsIBA
02/2016 - 11/2015
2RNA (Ribonucleic Acid)IBA
02/2016 - 03/2015
1Dexamethasone (Maxidex)FDA LinkGeneric
10/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2022
1Inflammation MediatorsIBA
01/2022
1schizandrinIBA
01/2022
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
09/2021
1LipidsIBA
09/2021
1Capsules (Microcapsules)IBA
07/2021
1Pharmaceutical PreparationsIBA
02/2021
1Drug CarriersIBA
02/2021
1GlycerophosphatesIBA
02/2021
1ChitosanIBA
02/2021
1Ophthalmic Solutions (Eye Drops)IBA
02/2021
1Adalimumab (Humira)FDA Link
02/2021
1TeaIBA
01/2021
1Tumor Biomarkers (Tumor Markers)IBA
01/2021
1imperatorinIBA
01/2021
1poly-N-isopropylacrylamideIBA
11/2020
1Ribosomal Protein S6IBA
08/2020
1Ribosomal Proteins (Ribosomal Protein)IBA
08/2020
1Retinaldehyde (Retinal)IBA
01/2020
1triacetyl-3-hydroxyphenyladenosineIBA
10/2019
1rucaparibIBA
01/2019
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2019
1pyrimidineIBA
08/2018
1purineIBA
08/2018
1InterferonsIBA
06/2018
1Etoposide (VP 16)FDA LinkGeneric
01/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2018

Therapy/Procedure

4Therapeutics
03/2020 - 12/2014
2Drug Therapy (Chemotherapy)
01/2018 - 01/2018
1Microspheres (Microsphere)
05/2022
1Chinese Traditional Medicine (Traditional Chinese Medicine)
07/2021
1Intravitreal Injections
02/2021
1Blood Transfusion (Blood Transfusions)
01/2021
1Operative Time
01/2021
1Length of Stay
01/2021
1Curettage
01/2021
1Uterine Artery Embolization
01/2021
1Phototherapy (Light Therapy)
11/2020
1Vitrectomy
07/2020
1Refractive Surgical Procedures
07/2020
1Lasers (Laser)
07/2020
1Phacoemulsification
07/2020
1Lenses
01/2020
1Hysterectomy
01/2019
1Lymph Node Excision (Lymph Node Dissection)
01/2019
1Aftercare (After-Treatment)
01/2019
1Radiotherapy
01/2019